We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+33.91%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$533M
AUM Growth
+$126M
Cap. Flow
+$52.5M
Cap. Flow %
9.87%
Top 10 Hldgs %
94.83%
Holding
23
New
2
Increased
7
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$7.1M
2
DERM
Dermira, Inc.
DERM
+$6M
3
AMRN
Amarin Corp
AMRN
+$3.6M
4
AGEN
Agenus
AGEN
+$3.29M
5
COR icon
Cencora
COR
+$2.14M

Top Sells

Rank Stock Value
1
OPK icon
Opko Health
OPK
+$2.41M
2
AXDX
Accelerate Diagnostics
AXDX
+$2.23M
3
QDEL icon
QuidelOrtho
QDEL
+$1.77M
4
CFRX
ContraFect Corporation
CFRX
+$1.05M
5
BIIB icon
Biogen
BIIB
+$416K

Sector Composition

Rank Sector Weight
1 Healthcare 90.46%
2 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.14B
$132M 24.75%
1,756,988
-27,476
-2% -$1.77M
AMRN
2
Amarin Corp
AMRN
$293M
$112M 21.04%
261,300
+9,489
+4% +$3.6M
BHVN
3
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$105M 19.66%
1,923,290
+143,415
+8% +$7.1M
AXDX
4
DELISTED
Accelerate Diagnostics
AXDX
$71.2M 13.37%
421,315
-13,499
-3% -$2.23M
DERM
5
DELISTED
Dermira, Inc.
DERM
$38.3M 7.2%
2,528,311
+694,526
+38% +$6M
SLNO
6
DELISTED
Soleno Therapeutics
SLNO
$11.4M 2.14%
258,042
– –
AGEN
7
Agenus
AGEN
$275M
$11.3M 2.12%
141,239
+49,106
+53% +$3.29M
MOTS
8
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$8.72M 1.64%
12,689
– –
VRML
9
DELISTED
Vermillion, Inc.
VRML
$7.96M 1.49%
9,825,289
– –
AMRN
10
CALL
Amarin Corp
AMRN
$293M
$7.66M 1.44%
97,980
+91,980
+1,533% +$34.9M
OPK icon
11
Opko Health
OPK
$1.25B
$6.43M 1.21%
4,373,076
-1,437,300
-25% -$2.41M
PACB icon
12
Pacific Biosciences
PACB
$432M
$5.71M 1.07%
1,110,666
– –
ATRS
13
DELISTED
Antares Pharma, Inc.
ATRS
$3.23M 0.61%
688,237
+400,000
+139% +$1.64M
QDEL icon
14
CALL
QuidelOrtho
QDEL
$1.14B
$3.11M 0.58%
247,700
+173,800
+235% +$11.2M
BIOL
15
DELISTED
Biolase, Inc.
BIOL
$2.86M 0.54%
2,069
– –
COR icon
16
Cencora
COR
$62.2B
$2.13M 0.4%
+25,000
New +$2.14M
AXDX
17
CALL
DELISTED
Accelerate Diagnostics
AXDX
$1.5M 0.28%
48,350
-41,660
-46% -$6.88M
BIIB icon
18
Biogen
BIIB
$30.4B
$1.44M 0.27%
4,868
-1,500
-24% -$416K
CFRX
19
DELISTED
ContraFect Corporation
CFRX
$933K 0.18%
1,878
-3,613
-66% -$1.05M
DB icon
20
Deutsche Bank
DB
$67.6B
$195K 0.04%
+25,000
New +$188K
XBI icon
21
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.1B
– –
-250,000
Closed -$51K
BHVN
22
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-596,000
Closed -$966K
BHVN
23
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-126,400
Closed -$1.81M

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, Oracle Investment Management held 23 positions worth $533M, up 31% from $407M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Oracle Investment Management deployed $52.5M of net new capital in Q4 2019, opening 2 new positions and adding to 7 existing holdings. Its largest new stake was Cencora: 25,000 shares worth $2.13M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 96% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Opko Health, an estimated $2.41M trimmed.

  • Oracle Investment Management's largest Q4 2019 buy was Cencora: 25,000 shares worth $2.13M.
  • Oracle Investment Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q4 2019, an estimated $7.1M increase.
  • Oracle Investment Management's biggest Q4 2019 reduction was Opko Health, cutting an estimated $2.41M.
  • Oracle Investment Management's ten largest holdings make up 95% of its $533M portfolio in Q4 2019.
  • Oracle Investment Management opened 2 new positions and closed 3 in Q4 2019.
  • Oracle Investment Management's portfolio value rose 31% quarter-over-quarter to $533M.

Based on Oracle Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.